In-vitro Diagnostics Enzymes Market Size, Share & Trends Report

In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-246-6
Number of Pages: 199
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

In-Vitro Diagnostics Enzyme Type Outlook (Revenue, USD Million, 2018 - 2030)
- Proteases
- Polymerase & Transcriptase
- Ribonuclease
- Others
In-Vitro Diagnostics Enzyme Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
- Infectious disease
  - COVID-19 Testing
  - Hepatitis
  - HIV
  - Others
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune diseases
- Others
In-Vitro Diagnostics Enzyme Technology Type Outlook (Revenue, USD Million, 2018 - 2030)
- Histology Assays
- Molecular Diagnostics
  - PCR Assays
  - NGS Assays
  - Others
- Clinical Chemistry
In-Vitro Diagnostics Enzyme End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharma & Biotech
- Hospital & Diagnostic Labs
- Contract Research Organizations (CROs)
- Academic Labs
In-Vitro Diagnostics Enzyme Regional Outlook (Revenue in USD Million, 2018 - 2030)
- North America
  - North America In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
    - Proteases
    - Polymerase & Transcriptase
    - Ribonuclease
    - Others
  - North America In-Vitro Diagnostics Enzyme, Disease Type Outlook
    - Infectious disease
      - COVID-19 Testing
      - Hepatitis
      - HIV
      - Others
    - Diabetes
    - Oncology
    - Cardiology
    - Nephrology
    - Autoimmune diseases
    - Others
  - North America In-Vitro Diagnostics Enzyme, Technology Type Outlook
    - Histology Assays
    - Molecular Diagnostics
      - PCR Assays
      - NGS Assays
      - Others
    - Clinical Chemistry
  - North America In-Vitro Diagnostics Enzyme, End-use Outlook
    - Pharma & Biotech
    - Hospital & Diagnostic Labs
    - Contract Research Organizations (CROs)
    - Academic Labs
  - U.S.
    - U.S. In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - U.S. In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - U.S. In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - U.S. In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Canada
    - Canada In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Canada In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Canada In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Canada In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
- Europe
  - Europe In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
    - Proteases
    - Polymerase & Transcriptase
    - Ribonuclease
    - Others
  - Europe In-Vitro Diagnostics Enzyme, Disease Type Outlook
    - Infectious disease
      - COVID-19 Testing
      - Hepatitis
      - HIV
      - Others
    - Diabetes
    - Oncology
    - Cardiology
    - Nephrology
    - Autoimmune diseases
    - Others
  - Europe In-Vitro Diagnostics Enzyme, Technology Type Outlook
    - Histology Assays
    - Molecular Diagnostics
      - PCR Assays
      - NGS Assays
      - Others
    - Clinical Chemistry
  - Europe In-Vitro Diagnostics Enzyme, End-use Outlook
    - Pharma & Biotech
    - Hospital & Diagnostic Labs
    - Contract Research Organizations (CROs)
    - Academic Labs
  - U.K.
    - U.K. In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - U.K. In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - U.K. In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - U.K. In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Germany
    - Germany In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Germany In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Germany In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Germany In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - France
    - France In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - France In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - France In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - France In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Italy
    - Italy In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Italy In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Italy In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Italy In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Spain
    - Spain In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Spain In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Spain In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Spain In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Sweden
    - Sweden In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Sweden In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Sweden In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Sweden In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Norway
    - Norway In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Norway In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Norway In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Norway In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Denmark
    - Denmark In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Denmark In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Denmark In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Denmark In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
- Asia Pacific
  - Asia Pacific In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
    - Proteases
    - Polymerase & Transcriptase
    - Ribonuclease
    - Others
  - Asia Pacific In-Vitro Diagnostics Enzyme, Disease Type Outlook
    - Infectious disease
      - COVID-19 Testing
      - Hepatitis
      - HIV
      - Others
    - Diabetes
    - Oncology
    - Cardiology
    - Nephrology
    - Autoimmune diseases
    - Others
  - Asia Pacific In-Vitro Diagnostics Enzyme, Technology Type Outlook
    - Histology Assays
    - Molecular Diagnostics
      - PCR Assays
      - NGS Assays
      - Others
    - Clinical Chemistry
  - Asia Pacific In-Vitro Diagnostics Enzyme, End-use Outlook
    - Pharma & Biotech
    - Hospital & Diagnostic Labs
    - Contract Research Organizations (CROs)
    - Academic Labs
  - China
    - China In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - China In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - China In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - China In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Japan
    - Japan In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Japan In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Japan In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Japan In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - India
    - India In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - India In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - India In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - India In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Australia
    - Australia In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Australia In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Australia In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Australia In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Thailand
    - Thailand In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Thailand In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Thailand In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Thailand In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - South Korea
    - South Korea In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - South Korea In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - South Korea In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - v In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
- Latin America
  - Latin America In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
    - Proteases
    - Polymerase & Transcriptase
    - Ribonuclease
    - Others
  - Latin America In-Vitro Diagnostics Enzyme, Disease Type Outlook
    - Infectious disease
      - COVID-19 Testing
      - Hepatitis
      - HIV
      - Others
    - Diabetes
    - Oncology
    - Cardiology
    - Nephrology
    - Autoimmune diseases
    - Others
  - Latin America In-Vitro Diagnostics Enzyme, Technology Type Outlook
    - Histology Assays
    - Molecular Diagnostics
      - PCR Assays
      - NGS Assays
      - Others
    - Clinical Chemistry
  - Latin America In-Vitro Diagnostics Enzyme, End-use Outlook
    - Pharma & Biotech
    - Hospital & Diagnostic Labs
    - Contract Research Organizations (CROs)
    - Academic Labs
  - Brazil
    - Brazil In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Brazil In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Brazil In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Brazil In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Mexico
    - Mexico In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Mexico In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Mexico In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Mexico In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Argentina
    - Argentina In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Argentina In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Argentina In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Argentina In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
- Middle East and Africa
  - Middle East and Africa In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
    - Proteases
    - Polymerase & Transcriptase
    - Ribonuclease
    - Others
  - Middle East and Africa In-Vitro Diagnostics Enzyme, Disease Type Outlook
    - Infectious disease
      - COVID-19 Testing
      - Hepatitis
      - HIV
      - Others
    - Diabetes
    - Oncology
    - Cardiology
    - Nephrology
    - Autoimmune diseases
    - Others
  - Middle East and Africa In-Vitro Diagnostics Enzyme, Technology Type Outlook
    - Histology Assays
    - Molecular Diagnostics
      - PCR Assays
      - NGS Assays
      - Others
    - Clinical Chemistry
  - Middle East and Africa In-Vitro Diagnostics Enzyme, End-use Outlook
    - Pharma & Biotech
    - Hospital & Diagnostic Labs
    - Contract Research Organizations (CROs)
    - Academic Labs
  - Saudi Arabia
    - Saudi Arabia In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Saudi Arabia In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Saudi Arabia In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Saudi Arabia In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - South Africa
    - South Africa In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - South Africa In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - South Africa In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - South Africa In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - UAE
    - UAE In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - UAE In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - UAE In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - UAE In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs
  - Kuwait
    - Kuwait In-Vitro Diagnostics Enzyme, Enzyme Type Outlook
      - Proteases
      - Polymerase & Transcriptase
      - Ribonuclease
      - Others
    - Kuwait In-Vitro Diagnostics Enzyme, Disease Type Outlook
      - Infectious disease
        
        COVID-19 Testing
        
        Hepatitis
        
        HIV
        
        Others
      - Diabetes
      - Oncology
      - Cardiology
      - Nephrology
      - Autoimmune diseases
      - Others
    - Kuwait In-Vitro Diagnostics Enzyme, Technology Type Outlook
      - Histology Assays
      - Molecular Diagnostics
        
        PCR Assays
        
        NGS Assays
        
        Others
      - Clinical Chemistry
    - Kuwait In-Vitro Diagnostics Enzyme, End-use Outlook
      - Pharma & Biotech
      - Hospital & Diagnostic Labs
      - Contract Research Organizations (CROs)
      - Academic Labs

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.